Scholars Central

Review articlePublished 30 May 2016

Current state and future prospects of pharmacological interventions for autism

Authors: Arshya Vahabzadeh, David Buxton, Christopher J McDougle, Kimberly A Stigler

Neuropsychiatry

Volume 3 · Issue 2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Autism spectrum disorder (ASD) is a group of heterogeneous developmental disorders manifesting in early childhood. They are associated with a range of core and associated symptoms, including repetitive behaviors, hyperactivity and irritability. This review will describe the current evidence for psychopharmacological management of individuals with ASD. Additionally, some of the future treatment prospects will be discussed. Safety issues, adverse effects and limitations of the current literature will also be highlighted.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Neuropsychiatry.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalNeuropsychiatry
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Arshya Vahabzadeh”
  • BylineArticles whose byline prints “David Buxton”
  • BylineArticles whose byline prints “Christopher J McDougle”
  • BylineArticles whose byline prints “Kimberly A Stigler”